Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

INFI

Infinity Pharmaceuticals (INFI)

Infinity Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INFI
DateTimeSourceHeadlineSymbolCompany
09/13/20237:11AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INFIInfinity Pharmaceuticals Inc
09/12/20235:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:INFIInfinity Pharmaceuticals Inc
09/11/20233:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INFIInfinity Pharmaceuticals Inc
09/01/20233:06PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INFIInfinity Pharmaceuticals Inc
08/10/20233:32PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INFIInfinity Pharmaceuticals Inc
07/25/20233:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INFIInfinity Pharmaceuticals Inc
07/25/20233:05PMBusiness WireInfinity Pharmaceuticals Announces Value Preservation and Maximization PlanNASDAQ:INFIInfinity Pharmaceuticals Inc
07/24/20237:35AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INFIInfinity Pharmaceuticals Inc
07/24/20237:30AMBusiness WireInfinity Pharmaceuticals Announces Termination of Merger Agreement with MEI PharmaNASDAQ:INFIInfinity Pharmaceuticals Inc
07/14/20233:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INFIInfinity Pharmaceuticals Inc
07/14/202312:00PMBusiness WireInfinity Pharmaceuticals Announces Stockholder Approval of Merger with MEI PharmaNASDAQ:INFIInfinity Pharmaceuticals Inc
07/10/20237:30AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INFIInfinity Pharmaceuticals Inc
07/10/20237:30AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INFIInfinity Pharmaceuticals Inc
07/10/20237:30AMBusiness WireInfinity Pharmaceuticals Provides Additional Information on MARIO-8 Study Evaluating Eganelisib in Combination with the PD-1 Targeted Checkpoint Inhibitor Pembrolizumab (KEYTRUDA®) in Patients with Squamous Cell Cancer of the Head and Neck (SCCHN)NASDAQ:INFIInfinity Pharmaceuticals Inc
07/05/20237:30AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INFIInfinity Pharmaceuticals Inc
07/05/20237:30AMBusiness WireISS Recommends Infinity Pharmaceuticals Stockholders Vote FOR the Merger with MEI Pharma, Inc.NASDAQ:INFIInfinity Pharmaceuticals Inc
07/03/20233:57PMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:INFIInfinity Pharmaceuticals Inc
07/03/20233:55PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INFIInfinity Pharmaceuticals Inc
07/03/20237:31AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INFIInfinity Pharmaceuticals Inc
06/30/20233:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INFIInfinity Pharmaceuticals Inc
06/29/20235:01AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INFIInfinity Pharmaceuticals Inc
06/27/20237:31AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INFIInfinity Pharmaceuticals Inc
06/21/20237:32AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INFIInfinity Pharmaceuticals Inc
06/20/20237:31AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INFIInfinity Pharmaceuticals Inc
06/20/20237:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INFIInfinity Pharmaceuticals Inc
06/16/202311:34AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INFIInfinity Pharmaceuticals Inc
06/16/20237:32AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INFIInfinity Pharmaceuticals Inc
06/15/202311:08AMBusiness WireMEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology CandidatesNASDAQ:INFIInfinity Pharmaceuticals Inc
06/15/20237:00AMBusiness WireMEI Pharma and Infinity Pharmaceuticals Host Video Webcast Providing Overview and Update on Pending Merger to Advance Three Promising Clinical Oncology CandidatesNASDAQ:INFIInfinity Pharmaceuticals Inc
06/06/20233:44PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INFIInfinity Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:INFI